TELA Bio makes soft tissue repair matrices used by surgeons for hernia repair and plastic and reconstructive surgery. TELA reports earnings on Tue, Nov 10, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 25 | Craig-Hallum | Initiated | Buy |
Seasonality
How TELA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
Whale Options Flow
90DNo whale options trades in TELA in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TELA is in one of them and how their past TELA trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered TELA in an article yet. Here's the latest on the wider market.
About TELA Bio
TELA Bio is a medical technology company based in Malvern, Pennsylvania. It sells soft tissue reconstruction products, mainly tissue matrices that surgeons use to repair hernias and to reinforce tissue in plastic and reconstructive surgery. The matrices are made from sheep tissue combined with polymer materials and are sold mainly to surgeons and hospitals in the United States and Europe. The company also distributes some complementary surgical products made by other manufacturers.
- Headquarters
- Malvern, PA